Article: Eon Labs Receives Approval for Lisinopril/HCTZ Tablets.

Business/Health Editors

Eon Labs, Inc. (Nasdaq:ELAB) announced today that it received final approval for Lisinopril/HCTZ Tablets, the generic alternative for the hypertension treatment Prinzide(R)(a).

Eon Labs approval is for the same strengths as the brand 10/12.5mg, 20/12.5mg and 20/25mg tablets. Shipments of Lisinopril/HCTZ will begin immediately. The approval of Lisinopril/HCTZ tablets is the 9th approval received by Eon Labs in 2002.

Eon Labs is a generic pharmaceutical company specializing in developing, licensing, manufacturing, selling and distributing a broad range of prescription pharmaceutical products. Eon's diverse product line ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!